文章摘要
陆辉志,付守芝,杨璐瑜,谭 赟,董 辉,廖友霞.不同剂量甲泼尼龙治疗老年AECOPD的疗效及其对炎症因子水平的影响比较[J].,2018,(12):2320-2324
不同剂量甲泼尼龙治疗老年AECOPD的疗效及其对炎症因子水平的影响比较
Comparison of the Curative Effects of Different Doses of Methylprednisolone in the Treatment of Elderly Patients with AECOPD and Its Influence on the Serum Inflammatory Factors Levels
投稿时间:2017-11-03  修订日期:2017-11-27
DOI:10.13241/j.cnki.pmb.2018.12.025
中文关键词: 剂量  甲泼尼龙  老年  AECOPD  炎症因子
英文关键词: Dose  Methylprednisolone  Elderly  AECOPD  Inflammatory factors
基金项目:湖北省科技计划项目(2015Sb2145)
作者单位E-mail
陆辉志 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060 luhuizhi372@163.com 
付守芝 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060  
杨璐瑜 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060  
谭 赟 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060  
董 辉 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060  
廖友霞 武汉市第三医院(武汉大学同仁医院)重症医学科 湖北 武汉 430060  
摘要点击次数: 552
全文下载次数: 250
中文摘要:
      摘要 目的:观察和比较不同剂量甲泼尼龙治疗老年慢性阻塞性肺疾病急性加重(AECOPD)的疗效及其对炎症因子的影响。方法:选取2014年1月到2017年1月收治的114例老年AECOPD患者,随机将患者分为A组、B组和C组各38例。A组采用甲泼尼龙40 mg/d静脉推注,B组采用甲泼尼龙80 mg/d静脉推注,C组不使用甲泼尼龙。对比三组患者的临床疗效以及治疗前后的改良版英国医学研究委员会呼吸问卷(mMRC)评分、动脉血氧分压(PaO2)、动脉二氧化碳分压(PaCO2)、下去白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)以及C反应蛋白(CRP)水平的变化。结果:治疗后,A组的总有效率为89.47 %,B组的总有效率为92.11 %,均显著高于C组(均P<0.05)。A组和B组治疗后的mMRC评分、PaCO2水平均显著低于C组,而PaO2水平显著高于C组(均P<0.05);B组治疗后的mMRC评分、PaCO2均显著低于A组,而PaO2显著高于A组(均P<0.05);A组和B组治疗后的血清IL-6、IL-8、TNF-α以及CRP水平均显著低于C组(均P<0.05);B组治疗后的血清IL-6、IL-8、TNF-α、CRP水平均显著低于A组(均P<0.05)。三组患者不良反应发生率的对比差异均无统计学意义(均P>0.05)。结论:与40 mg/d甲泼尼龙相比,短期80 mg/d甲泼尼龙静脉推注可更显著减轻AECOPD患者的炎症反应,提高临床疗效,同时具有良好的安全性。
英文摘要:
      ABSTRACT Objective: To observe and compare the curative effects of different doses of methylprednisolone in the treatment of el- derly patients with AECOPD and the influence on the serum inflammatory factors levels. Methods: 114 cases of elderly patients with AECOPD were selected from January 2014 to January 2017 and randomly divided into group A, group B and group C, 38 in each group. Group A was treated with methylprednisolone 40 mg/d intravenous injection. Group B was treated with methylprednisolone 80 mg/d in- travenous injection. Group C was treated without methylprednisolone. The curative effects were compared among the three groups. The changes of mMRC, PaO2 and PaCO2, serum IL-6, IL-8, TNF-α, and CRP levels were compared among the three groups before and after treatment. Results: The total efficiency of group A was 89.47 %, the total effective rate of group B was 92.11 %, which were significantly higher than that of group C(P<0.05). After treatment, the mMRC scores and PaCO2 of group A and group B were significantly lower than those of Group C, while the PaO2 were significantly higher than that of group C (P<0.05). After treatment, the mMRC score and PaCO2 of group B were significantly lower than that of group A, and PaO2 was significantly higher than that of group A (P<0.05). After treatment, the levels of IL-6, IL-8, TNF-α and CRP of group A and group B were significantly lower than those of group C (P<0.05). After treat- ment, the levels of IL-6, IL-8, TNF-α and CRP of group B were significantly lower than those of group A (P<0.05). Conclusion: Short-term intravenous injection with 80 mg/d methylprednisolone could more significantly reduce the inflammation in patients with AECOPD than 40 mg/d methylprednisolone, improve the clinical efficacy, and had good safety.
查看全文   查看/发表评论  下载PDF阅读器
关闭